Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
AssigneeMetaproteomics, LLC
InventorsJohn G. Babish, M. Terrence Howell
Life of this patent
Estimating the term…
Abstract
A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammation response in animals. The formulation comprises comprising an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the group consisting of alpha acids, beta acids, essential oils, fats and waxes, with the proviso that component I and II are not the same compound. The composition provides specific inhibition of cyclooxygenase-2 with little or no effect on cyclooxygenase-1.
Claims10
A method of dietary supplementation in animals comprising administering to an animal suffering symptoms of inflammation a composition for inhibition of inducible COX-2 activity and having less effect on COX-1 activity than on COX-2 activity, said composition comprising an effective amount of a CO2 extract of hops.
Dependencies are inferred from the claim text.